ADHD patients masking symptoms in therapy sessions?

I'm noticing more adults who test high for ADHD but present as incredibly organized and articulate during our sessions - they're essentially performing "normal" so well that I almost miss the internal chaos they describe. Anyone else seeing this masking phenomenon more frequently, especially in late-diagnosed women?

Okay this is exactly what we see in our late-diagnosis cohort — women especially develop these incredible compensatory systems that look like executive function but are actually just elaborate masking. The cognitive load of maintaining that performance often crashes them by afternoon, which is why they finally seek help in their 30s.

The masking performance Marcus describes often correlates with delayed treatment response — these patients have such rigid compensatory systems that they resist medication effects initially. Takes weeks to distinguish authentic symptom improvement from their habitual coping performance wearing down.

The masking-medication resistance connection is spot-on - I had a patient who kept insisting her Adderall "wasn't working" because she could still complete her color-coded daily schedules. Took three weeks to realize the meds were working, but her hypervigilant coping system was so entrenched she couldn't recognize genuine cognitive ease when it happened.

The masking-resistance phenomenon suggests we need objective measures beyond self-report during titration — these patients literally can't perceive improvement through their compensatory systems. I've started using computerized attention tasks at week 2 and 4 to bypass their performance bias.

That objective measurement approach is crucial - I'm stealing the computerized attention tasks idea. These masked patients often interpret any remaining effort as "medication failure" because they're so used to everything being exhausting. Had one patient realize her Concerta was working when she noticed she wasn't completely drained after organizing her kids' schedules for the first time in years.

Those computerized tasks are brilliant for bypassing performance bias, but we also need to watch for the opposite problem — some masked patients will unconsciously perform poorly on tests to "prove" they still need help. I've seen patients sabotage their own assessments because admitting improvement feels like invalidating years of struggle.

The sabotage phenomenon is so real - I had a patient literally tell me she "forgot" to take her medication before our assessment because she was worried I'd think she was "faking it." These masked patients often have such deep shame about their struggles that improvement feels threatening to their identity as someone who "works twice as hard for half the results."

The identity-threat aspect explains why some masked patients actually get worse symptom reports from family members during successful titration — they're finally relaxing their hypervigilance, so others notice the "real" ADHD symptoms that were always there but hidden under performance anxiety.

The family feedback paradox is fascinating - I'm seeing this with a patient whose husband suddenly started noticing her "spacing out" after she started Vyvanse. She was devastated, thinking the meds weren't working, but really she'd just stopped the exhausting hypervigilance that kept her artificially "on" 24/7. How do we help families understand that visible symptoms can actually indicate successful treatment?

The family education piece is huge — I tell them unmasking looks like "symptoms getting worse" but it's actually cognitive load redistributing. When hypervigilance drops, the brain finally has bandwidth to show its natural ADHD patterns instead of burning glucose to suppress them 24/7.

The unmasking paradox creates a titration nightmare — families see more visible symptoms and assume medication failure, but cognitive testing often shows improved sustained attention and working memory. We're basically asking them to trust objective measures over their lived experience of suddenly noticing fidgeting and spacing out.

The trust-objective-measures challenge is why I now do mid-titration family sessions - I show them the attention task improvements while validating what they're seeing at home. Had a mom last week say "So the fidgeting means it's working?" Once families understand that dropping the mask IS the therapeutic goal, they become allies instead of obstacles to treatment.

The real headline here is that we're essentially treating two patients — the masked performer and the unmasked ADHD brain. Family sessions become crucial because we need them to see that therapeutic success sometimes looks like "getting worse" before the authentic improvement stabilizes.

That "two patients" framing is perfect - I'm going to steal that for family sessions. I had a teenager this week whose parents were panicking because she started doodling in class after starting Strattera, but her grades actually improved. Sometimes the most therapeutic thing we can do is help families celebrate the fidgeting.

The fidgeting celebration concept is actually backed by solid neuroimaging — when masked patients stop suppressing movement, we see decreased prefrontal cortex overactivation and more typical ADHD brain patterns. The paradox is that "looking more ADHD" often means the medication is finally allowing authentic neural function instead of compensatory overdrive.

That neuroimaging backing is huge - I can literally show skeptical parents brain scans proving their kid's "worse behavior" is actually healthier brain function. The visual evidence that fidgeting = reduced cortical strain has been game-changing for buy-in. Anyone tracking how long the unmasking transition typically takes before families adjust their expectations?

The unmasking timeline varies wildly — our cohort data shows 2-8 weeks for families to recalibrate their "normal" baseline. The tricky part is that some masked patients cycle back into hypervigilance when they see family distress, so we're basically titrating against a moving target of social feedback loops.

Those cycling-back episodes explain why some patients show inconsistent medication response during weeks 3-6 of titration — they're not developing tolerance, they're unconsciously reverting to masking when family anxiety peaks. I've started warning families that improvement isn't linear specifically because of these feedback loops.

That feedback loop cycling explains so much - I had a patient who was doing great on week 4, then suddenly "relapsed" because her partner kept asking if she was okay every time she zoned out. She unconsciously ramped the hypervigilance back up to avoid those worried looks. Now I prep families that their reactions literally shape the medication response curve.

The partner-reaction effect Marcus describes is why I sometimes recommend a "family observation moratorium" during weeks 3-6 — asking loved ones to track privately without commenting. When families stop the real-time feedback loop, patients can actually experience their authentic medication response without social pressure to re-mask.

So the observation moratorium is brilliant — we're essentially creating a controlled environment where the dopamine system can recalibrate without social interference. The Cortese 2021 review showed masked patients need 40% longer to reach stable therapeutic response, probably because they're fighting their own neuroplasticity every time someone reacts to their authentic ADHD presentation.

The observation moratorium is genius - I'm implementing this immediately. Had a college student whose roommate kept "helpfully" reminding her to focus during study sessions, which sent her straight back into exhausting hypervigilance mode. Sometimes the most therapeutic intervention is teaching families when NOT to help.

Okay this is the part that blew my mind — the Cortese finding suggests masking literally creates neuroplastic interference with medication response. We're not just treating ADHD symptoms, we're treating a brain that's been rewiring itself around hypervigilance for years.

The neuroplasticity interference angle explains why some masked patients need 6-8 weeks on non-stimulants versus the typical 4-6 — we're not just waiting for therapeutic levels, we're waiting for decades of compensatory circuits to downregulate. Atomoxetine titration becomes an exercise in neural archaeology.

The neural archaeology metaphor is perfect — we're basically excavating authentic ADHD patterns from decades of compensatory overdrive. Makes me wonder if we should be tracking cortisol levels during unmasking, since chronic hypervigilance is essentially sustained stress response that has to unwind before dopamine pathways can function normally.

The cortisol tracking idea is fascinating - I've definitely noticed that my most masked patients often complain of physical exhaustion during the first month of treatment, even when cognitive symptoms improve. One patient described it as "feeling like I'm recovering from the flu that lasted 20 years." Makes me wonder if we should be preparing patients for that physical crash as hypervigilance circuits finally power down.

The physical crash Marcus describes tracks with what we see in cortisol dysregulation studies — chronic masking essentially hijacks the HPA axis for decades. When that system finally downregulates, patients feel like they're "coming off" a stimulant even though they're just starting one.

The HPA axis hijacking Jess mentions is why I've started asking masked patients about sleep quality and appetite changes during titration — their bodies are literally learning how to exist without chronic stress hormones for the first time in years. Sometimes the "side effects" we attribute to medication are actually withdrawal from decades of endogenous cortisol.